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Abstract
Objectives: To determine whether or not the antioxidants N-acetylcysteine (NAC) and allopurinol (ALP) confer synergistic
cardioprotection against myocardial ischemia/reperfusion (MI/R) injury by stabilizing hypoxia inducible factor 1a (HIF-1a)/
heme oxygenase 1 (HO-1) signaling in diabetic myocardium.
Methods: Control or diabetic [streptozotocin (STZ)-induced] Sprague Dawley rats received vehicle or NAC, ALP or their
combination for four weeks starting one week after STZ injection. The animals were then subjected to thirty minutes of
coronary artery occlusion followed by two hours reperfusion in the absence or presence of the selective HO-1 inhibitor, tin
protoporphyrin-IX (SnPP-IX) or the HIF-1a inhibitor 2-Methoxyestradiol (2ME2). Cardiomyocytes exposed to high glucose
were subjected to hypoxia/re-oxygenation in the presence or absence of HIF-1a and HO-1 achieved by gene knock-down
with related siRNAs.
Results: Myocardial and plasma levels of 15-F2t-isoprostane, an index of oxidative stress, were significantly increased in
diabetic rats while cardiac HO-1 protein and activity were reduced; this was accompanied with reduced cardiac protein
levels of HIF-1a, and increased post-ischemic myocardial infarct size and cellular injury. NAC and ALP given alone and in
particular their combination normalized cardiac levels of HO-1 and HIF-1a protein expression and prevented the increase in
15-F2t-isoprostane, resulting in significantly attenuated post-ischemic myocardial infarction. NAC and ALP also attenuated
high glucose-induced post-hypoxic cardiomyocyte death in vitro. However, all the above protective effects of NAC and ALP
were cancelled either by inhibition of HO-1 or HIF-1a with SnPP-IX and 2ME2 in vivo or by HO-1 or HIF-1a gene knock-down
in vitro.
Conclusion: NAC and ALP confer synergistic cardioprotection in diabetes via restoration of cardiac HIF-1a and HO-1
signaling.
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Introduction
Myocardial infarction is a major perioperative complication
that is associated with significant mobility and mortality,
particularly in patients with diabetes. Reperfusion therapies
restore coronary flow, but reperfusion may itself cause lethal
tissue injury termed ischemia reperfusion injury (IRI) [1]. The
mortality is higher in patients with diabetes after acute myocardial
ischemia with or without coronary artery bypass grafting surgery
to restore blood perfusion [2,3]. Excessive production of reactive
oxygen species (ROS) and the subsequent increase in oxidative
stress under high glucose conditions plays a critical role in this
pathology [4].
Stabilization of hypoxia-inducible factor-1 (HIF) improves
ventricular performance, remodeling, and vascularization after
myocardial infarction in rats [5]. HIF is a key regulator in response
to low-oxygen (O2) conditions (hypoxia/anoxia) [6]. It is a
heterodimer consisting of an inducible a subunit and a constitu-
tively expressed b subunit; its activity is determined by stable
expression of the a-subunit [7]. HIF-1a is increased in the
euglycemic heart in response to ischemia, while HIF-1a -mediated
cellular responses to hypoxia are blunted in hyperglycemic rats
[8,9], but the underlying mechanism is unclear. Heme oxygenase-
1 (HO-1) is a down-stream protein of HIF-1a and plays a key role
in protecting the heart against ischemic injury [10]. Inhibition of
HO-1 gene expression [11] or HO-1 gene knock-down [12]
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exacerbates while HO-1 gene overexpression [13,14] attenuates
myocardial infarction and ventricular arrhythmias after myocar-
dial ischemia and reperfusion in mice. Induction of HO-1 occurs
as an adaptive defensive mechanism in response to a variety of
stimuli including oxidative stress and hypoxia [15,16] while HO-1
is reduced in the diabetic myocardium after ischemia reperfusion
injury [17]. HIF-1a mediated up-regulation of HO-1 is beneficial
to the ischemic myocardium in non-diabetic rodents [10], but
related information under diabetic conditions is lacking. Thus, it is
possible that treatments that enhance myocardial HIF-1a/HO-1
expression in response to ischemia reperfusion under hyperglyce-
mic conditions should confer cardioprotection in diabetes.
HIF-1a production is decreased under oxidative conditions [18]
and the deficiency in HIF-1a results in increased myocardial
damage in response to ischemic insult [19]. In diabetes, the high
glucose levels favor the production of ROS as a result of glucose
auto-oxidation, metabolism and the development of advanced
glycosylation end products [4]. Superoxide dismutase (SOD) is a
major endogenous antioxidant enzyme but its ROS scavenging
ability is decreased under hyperglycemic conditions [20]. Likewise,
the reduced HIF-1a expression in the diabetic myocardium is
associated with decreased tolerability to myocardial ischemic insult
[8,21]. However, the link between hyperglycemia induced
increases in oxidative stress and decreases in myocardial HIF-1a
in the context of myocardial ischemia-reperfusion has not been
elucidated. The antioxidants N-acetylsysteine (NAC) and allopu-
rinol (ALP), when applied individually at a dose that is sufficient to
completely prevent hyperglycemia-induced oxidative stress in
diabetic rats, each moderately reduced post-ischemic myocardial
infarction, while their combined administration profoundly
reduced infarct size [22] without further reduction in either
cardiac or systemic levels of 15-F2t isoprostane, a specific index of
ROS-induced oxidative stress [23]. This finding suggests that
NAC and ALP may have exerted synergistic cardioprotection via
mechanisms not limited to boosting antioxidant capacity. Given
that HIF-1a deficiency exacerbates myocardial IRI and that
cardiac HIF-1a is decreased in diabetes [24], we postulated that
reduction in myocardial HIF-1a expression as a result of high-
glucose induced oxidative stress may be a major mechanism
explaining why diabetic hearts are less resistant to IRI than those
from non-diabetic subjects. Further, we hypothesized that
enhancement of endogenous myocardial HIF-1a is a key
mechanism whereby antioxidants NAC and ALP confer synergis-
tic cardioprotection against myocardial IRI in diabetes. This
hypothesis was tested in vivo in type 1 diabetic rats and in isolated
adult rat cardiomyocytes and H9C2 cell line subjected to hypoxia/
re-oxygenation in vitro.
Materials and Methods
In Vivo Studies
Experimental animals. Male adult Sprague-Dawley with
streptozotocin (STZ)-induced diabetes and age-matched non-
diabetic control rats were used. All rats (250610 g, 6–8 weeks)
were obtained from and housed in the Laboratory Animal Service
Center (University of Hong Kong) and received standard care in
accordance with the principles of Animal Care of the University of
Hong Kong. The committee on the Use of Live Animals in
Teaching and Research (CULATR) approved the experimental
protocols.
Induction of diabetes and antioxidant treatment. Type 1
diabetes was induced as described [22]. Some of the diabetic rats
were treated with NAC or ALP (Sigma-Aldrich, St. Louis, MO,
USA) alone or in combination. The duration of the treatment was
four weeks, starting one week after induction of diabetes. The
optimal dosages of NAC and ALP were selected according to our
preliminary dose-finding experiment. We started with relatively
low dosages of NAC (0.5 g/kg/day) and ALP (50 mg/kg/day) as
used respectively in the studies of Fiordaliso et al [25] and Xiao
et al [26]. NAC when given at 0.5 g/kg/day for 3 months could
partially attenuate hyperglycemia-induced myocardial oxidative
stress and cardiac cell death [25] in diabetic rats, while ALP when
given at 50 mg/kg/day for 4 weeks did not significantly reduce
post-ischemic myocardial infarction despite that it could partially
reduce myocardial ROS production [26]. Since these two
antioxidants targeting different components of ROS [27,28], we
explored whether or not the combinational use of NAC at 0.5 g/
kg/day (low dose NAC) and ALP at 50 mg/kg/day (low dose
ALP) could confer cardioprotection against MI/R, and compared
with the effects of relatively higher doses of NAC (1.5 g/kg/day
[22,29] ) and/or ALP (100 mg/kg/day [22] [30]). STZ-induced
diabetic rats were treated for 4 weeks with the respective
antioxidants above-mentioned starting at 1 week after the
induction of diabetes, before being subjected to 30 minutes
coronary ligation followed by two hours of reperfusion. We found
that neither low-dose NAC nor low-dose ALP, alone or in
combination could significantly reduce post-ischemic myocardial
infarction in diabetic rats while NAC (1.5 g/kg/day) and ALP
(100 mg/kg/day) conferred synergy in reducing post-ischemic
myocardial infarction (Fig. 1A and B). Base on the above dose-
finding studies, NAC at 1.5 g/kg/day and ALP at 100 mg/kg/day
were used the subsequent experiments. Blood samples were
withdrawn from the inferior vena cava, and plasma was extracted
and stored at 280uC until being analysis. The left ventricle was
removed and rinsed with ice-cold phosphate buffered saline, and
weighed. Subgroups of rats were subjected to myocardial ischemia
reperfusion (MI/R) as described [22].
Effects of NAC and ALP on MI/R in STZ-induced
diabetes. The diabetic and the age-matched normal rats were
randomly divided into five groups of seven rats each: Control
group(C), untreated diabetic rats (D), diabetic rats treated with
NAC (D+N) or ALP (D+A) alone or in combination (D+NA).
Previous studies show that at the doses used, NAC and ALP do not
significantly affect myocardial levels of the lipid peroxidation
product 15-F2t-isoprostane in control rats [31]. Subsequently,
ALP and NAC were only given to diabetic rats in the current
study. The rats were subjected to coronary ligation as described
below.
Effects of HIF-1 a/HO-1 inhibition. Six groups of seven
rats each [sham-operated (Sham group), control(C group), diabetic
(D group), diabetics treated with NAC plus ALP (D+NA group)
diabetic treated with NAC plus ALP concomitant administrations
of the HIF-1a blocker 2-methoxyestradiol (D+NA+2ME2 group),
or diabetic treated with NAC plus ALP and the HO-1 blocker ()
(D+ NA+SnPP-IX group)] were subjected to in vivo coronary
ligation as described above. 2-Methoxyestradiol (2ME2; Sigma-
Aldrich, St. Louis, MO, USA) was administrated at15 mg/kg
intraperiteonally [32] before inducing ischemia. Tin protoporphy-
rin-IX (SnPP-IX; Sigma-Aldrich) was given at 0.7 mg/kg [33]
intravenously for two days before inducing coronary ischemia.
Echocardiography. M-mode echocardiographic studies
were performed at termination using a 17.5 MHz liner array
transducer system (Vevo 770TM High Resolution Imaging
System; Visual Sonics, Toronto, Canada) as described [34]. Left
ventricular contractile and diastolic function parameters were
measured and calculated as described [31,34]. Three representa-
tive cardiac cycles were recorded and averaged for each
measurement.
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Figure 1. Myocardial ischemia reperfusion injury assessed after 30 minutes of ischemia followed by two hours of reperfusion in
control and diabetic rats with or without treatment. Statistical analysis of the ratio of the area at risk (AAR)/left ventricle (LV) (A, C) and percent
infarct size (IS) expressed as a ratio to the AAR (B, D) and plasma CK-MB levels (E). In a preliminary dose-finding study (A, B), rats were treated with low
doses of N-acetylcysteine (NAC) (0.5 g/kg/day, Low NAC) or allopurinol (ALP) (50 mg/kg/day, Low ALP) or their combination (Low NA), or relatively
HIF-1a Signaling in Antioxidants Cardioprotection
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In vivo coronary ligation model and infarct size (IS)
determination. Rats were subjected to 30 minutes of left
anterior descending artery (LAD) ligation followed by two hours of
reperfusion as described [22]. The in vivo MI/R model of 30
minutes LAD occlusion and two hours of reperfusion was chosen
based on preliminary studies which showed that the majority of
the diabetic rats did not survive 60 minutes of LAD occlusion.
Likewise, although the diabetic rats could withstand 45 minutes of
LAD occlusion, the resulting post-ischemic myocardial infarct size
was much higher than that in the control rats (n = 4–5/group, data
not shown) and hence the diabetic animals subjected to 45 minutes
of LAD occlusion did not survive for two hours during post-
ischemic reperfusion. Hemodynamics was continuously monitored
using PowerLab monitoring system (ML750 PowerLab/4 sp with
MLT0380 Reusable BP Transducer; AD Instruments, CO
Springs, CO, USA). Myocardial infarct size (IS) was measured
using TTC (1% 2, 3, 5-triphenyltetrazolium chloride) staining as
described [35]. IS was expressed as a percentage of the area at risk
(AAR). Creatinine kinase-MB (CK-MB) isoenzyme is a major
biomarker for myocardial cellular injury and CK-MB content was
measured using a commercial kit (Uscn Life Science Inc. Wuhan,
China) in blood samples collected after two hours reperfusion.
In situ apoptotic cell death detection. TdT-mediated
DUTP-X nick end labeling (TUNEL stain) was employed to
detect apoptotic cell death according to the manufacturer’s
instruction (Roche Applied Science, Indianapolis, IN, USA).
Briefly, paraffin embedded left ventricular tissue was sliced (5-mm
thick sections) and deparaffinized. Subsequently, the sections were
permeabilized using proteinase K (30 mg/ml, 30 minutes, 37uC)
and were washed in phosphate buffered saline (PBS). The sections
were then incubated with TUNEL reaction mixture for 60
minutes and washed twice in PBS. Sections were incubated with
anti-fluorescein POD followed by the addition of DAB and
examined under a light microscope. As a positive control, DNase I
was used to induce DNA strand breaks. For the negative control,
TdT was omitted from the reaction mixture. The number of
TUNEL-positive cardiac myocytes (which were stained brown)
was determined by counting them within defined areas (30630
grids) of each slide and the average of ten histological sections was
reported as means 6 S.D. All morphometric measurements were
carried out by two independent expert examiners in a blinded
manner and results of the treated groups were expressed in
comparison to the control group.
Plasma and cardiac free 15-F2t-IsoP and SOD
measurement. Free 15-F2t-IsoP, a specific marker of oxidative
stress in vivo, was measured by using an enzyme immunoassay kit
(Cayman Chemical, Ann Arbor, MI, USA) as described [27]. The
value of plasma free 15-F2t-IsoP was expressed as pg/mL in
plasma. Myocardial SOD activity was detected in cardiac tissue
homogenates using commercially available kits (Cayman Chem-
ical) as described previously [36]. Myocardial reduced/oxidized
glutathione couple (GSH/GSSG) ratio was measured in cardiac
tissue also using a commercially available assay kit (Sigma-Aldrich)
according to the manufacturer’s protocol.
In Vitro Studies
Isolation of adult rat cardiomyocytes and hypoxia/re-
oxygenation (H/R). Isolated primarily cultured adult rat
cardiomyocytes were prepared as described [22]. The cells were
treated with high glucose (25 mM glucose in the culture medium)
to mimic the diabetic state for 48 hours before being subjected to
H/R. Hypoxic conditions were achieved by equilibrating a
humidified chamber containing myocytes with 95% N2 and 5%
CO2 via a gas transfusion apparatus (BioSpherix, Redfield, NY,
USA) and hypoxia was confirmed by demonstrating a chamber O2
concentration not higher than 0.1%. After 45 minutes of hypoxia,
the cells were transferred to room air (CO2 incubator) to achieve
re-oxygenation. After 120 minutes of re-oxygenation, the cells and
the medium were collected and stored at 280uC until analysis.
Effects of HIF-1a/HO-1 inhibition. The primarily cultured
adult rat cardiomyocytes were randomly divided into six groups:
non-H/R control (C), H/R control (H/R), high glucose (25 mM)
medium (H-G), H-G treated with 1 mM NAC (H-G+N) or with
100 mM ALP (H-G+A), with NAC plus ALP(H-G+NA), with
NAC plus ALP in the presence of 2ME2 (H-G+NA+2ME2) 5 mM
[37] or with NAC plus ALP in the presence of SnPP-IX(H-G+
NA+ SnPP-IX)10 mM [38]. Cells were transferred to freshly
prepared culture medium with or without inhibitors for 45
minutes before being subjected to 45 minutes of hypoxia and two
hours of re-oxygenation. The concentrations of NAC and ALP
higher doses of NAC (1.5 g/kg/day) or ALP (100 mg/kg/day) or their combination (NA), for a duration of 4 weeks before being subjected to
myocardial ischemia reperfusion. Data are mean 6 S.E.M. (n = 4–5 per group), *P,0.01 vs. I/R group, #P,0.01 vs. NAC group and &P,0.01 vs. ALP
group. Low NAC plus low ALP only moderately (P.0.1 vs. group I/R) attenuated post-ischemic myocardial IS. Therefore, the subsequent studies were
performed in rats treated with high doses of NAC and/or ALP (C–E). Sham, C and D indicate sham operation, control or diabetes respectively. D+N,
D+A, D+NA, D+NA +SnPP-IX, D+NA+2ME2 indicate control or diabetic rats respectively treated with NAC (N), ALP (A), NAC+ALP (NA) or NA+SnPP-IX or
NA +2ME2. Data are expressed as mean 6 S.E.M. (n = 7). ˆP,0.05 or P,0.01 vs. C; *P,0.05 or P,0.01 vs. D, $P,0.05, or P,0.01 vs. D+NA.
doi:10.1371/journal.pone.0068949.g001
Table 1. Effect of N-acetylcysteine and allopurinol on general characteristics in controls and rats with STZ- induced diabetes.
Parameters C D D+N D+A D+NA
Water intake (ml/kg/day) 120.662.5 790.4611.2a 415.567.2ab 679.6610ab 455.367.3ab
Food consumption (g/kg/day) 65.564.5 180.1612.3a 135.6613.3ab 179.768.5a 159.868.1ab
Body weight (g) 455.7613.3 320.968.5a 299.1610.1a 289.6611.6a 291.6618.5a
Plasma glucose (mM) 6.160.3 29.361.5a 29.361.0a 26.961.1a 27.961.1a
Heart/Body weight ratio (g/kg) 3.360.2 4.660.5a 3.560.2b 4.060.1 3.860.1b
Data are expressed as means6 S.E.M. (n = 7). Water intake, food consumption are the average value of four weeks. Body weight, plasma glucose are measured at
termination of administration. Control (C), diabetes (D), N- acetylcysteine (NAC), allopurinol (ALP),
ap,0.05 vs. C;
bp,0.05 vs. D.
doi:10.1371/journal.pone.0068949.t001
HIF-1a Signaling in Antioxidants Cardioprotection
PLOS ONE | www.plosone.org 4 July 2013 | Volume 8 | Issue 7 | e68949
used were selected based on previous studies [39] [40], and the
results of preliminary cell culture experiments indicating that NAC
did not confer cellular protection against H/R injury at either low
concentrations (0.1 mM to 0.3 mM) or at 3 mM, while that ALP
conferred cellular protection at 100 mM but not at 10 to 30 mM or
at 300 mM(data not shown). In addition, concomitant adminis-
tration of NAC and ALP at low (0.3 mM NAC with 30 mM ALP)
or at high (3 mM NAC with 300 mM) concentrations did not
confer significant cellular protection (data not shown).
Transfection and siRNA knockdown in H9C2 cells. Gene
silencing was performed using HIF-1 a siRNA, HO-1 siRNA,
control siRNA and transfection reagent, purchased from Santa
Cruz Biotechnology, Dallas, Texas, USA. Transfection of H9C2
cells was performed following the manufacturer’s instructions.
Briefly, 26105 H9C2 cells were seeded in a six well tissue culture
plate in 2 ml of antibiotic-free normal growth the cells were
allowed to reach 60–80% confluence. They then were transfected
with targeted siRNA and control siRNA. Six hours after the
transfection, normal growth medium was added and the cells were
incubated at 37uC in a CO2 incubator for 24 hours. Then, the
cells randomly divided into six groups: control, high-glucose
(25 mM), high-glucose and NAC (1 mM) plus ALP (100 mM),
high-glucose and NAC plus ALP treated with control siRNA,
high-glucose and NAC plus ALP treated with HIF-1a siRNA, and
high-glucose and NAC plus ALP treated with HO-1 siRNA. Two
days after the treatment, the cells were challenged with 45 min
hypoxia-120 min re-oxygenation and used for Western blotting or
lactate dehydrogenase (LDH) determination.
Cell viability and lactate dehydrogenase (LDH)
activity. Cardiomyocyte viability was determined by measuring
3-(4, 5- Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) reduction ability of cardiomyocytes as described [22].
LDH content was measured by LDH Cytotoxicity Assay Kit
(Cayman chemical,) using culture medium as described [41].
HIF-1a/HO-1 protein expression and HO-1
activity. Frozen ventricular tissue samples were homogenized
in lysis buffer. For the culture experiments, the cells were removed
upon completion of the incubation period, immediately mixed
with cell lysis buffer and then sonicated for ten seconds. The
samples were processed for Western blotting analysis following
standard methodology as described [22]. Primary antibody of
HO-1 (Cell Signaling Technology, Beverly, MA) 1:500; HIF-1a
(Abcam Biochemicals, Cambridge, MA) and GAPDH (Cell
Signaling Technology) 1:1000 were used. Protein bands were
detected by a standard ECL method and images were measured
by a densitometer with analysis software. Myocardium HO-1
activity was measured by spectrophotometric determination of
bilirubin formation according to the manufacturer’s instructions
(Genmed Scientifics, Arlington, MA, USA). HO-1 activity was
calculated as percentage of control.
Mitochondrial membrane potential and
apoptosis. Primary cultured cardiomyocytes and H9C2 cells
were cultured and treated as described above. After hypoxia/re-
oxygenation, the cardiomyocyte mitochondrial potential (MMP)
was checked using a JC-1 mitochondrial membrane potential
ELISA kit (Cayman Chemical) according to the manufacturer’s
protocol. JC-1 stained cells were analyzed using a Live Cell
Microscope (Nikon, Melville, New York, USA) (magnification,
610) and MMP loss was checked using a luminometer (GloMax;
Promega, Madison, Wisconsin, USA) and expressed as the
percentage of green cells in the total cells. Scale bar: 100 mm.
Cytosolic cytochrome c, Mn SOD and caspase3 protein
expression were measured in primary cultured cardiomyocyte
and in H9C2 cell by Western blotting as described [42,43].
Cytosolic proteins were isolated as described [44]. Primary
antibodies for cytochrome c, caspase3, cleaved caspase3 and Mn
SOD were purchased from Cell Signaling (Cell Signaling).
Statistical analysis
All values are expressed as means 6 standard error of the mean
(S.E.M.). One-way analysis of variance (ANOVA) was used for
statistical analyses (GraphPad Prism, USA) of data obtained within
the same group and between groups, respectively, followed by
Tukey’s test for multiple comparisons of group means. P values less
than 0.05 were considered to indicate statistically significant
differences.
Table 2. M-mode echocardiographic and transmitral Doppler flow velocity indices of LV dimension and functions.
Parameters C D D+N D+A D+NA
HR (bpm) 317613 281623a 286624a 273629a 281627a
LVIDd (mm) 8.2960.56 7.9660.76a 7.8260.29a 7.6760.58 7.5760.57a
LVIDs (mm) 4.7060.49 4.5060.49 4.6760.64 4.1360.59a 4.1060.34a
LVVd (ml) 371.69657.01 318.19661.03a 319.44645.2a 344.11656.49 297.44650.40a
LVVs (ml) 107.83626.11 92.647624.78 101.60632.59 76.90625.23ab 73.54621.89ab
LVEF (%) 71.7865.56 71.0464.45 68.3267.35 77.3265.45ab 75.7864.34ab
IVRT (ms) 22.3562.64 31.3464.66 29.3463.67 27.3262.66 29.3262.54
E/A 1.5060.12 1.2060.03 1.5460.11 1.6760.23 1.7660.43
SV (ml) 263.87643.09 225.38642.67a 217.90630.0 267.30641.6b 223.66636.47
LVM (mg) 931.326126.56 840.236123.54a 704.45691.6ab 768.32685.65ab 703.346118.65ab
BW (g) 513.75633.57 332.67647.34a 336.77631.4s 338.54640.78a 310.23626.67a
LVM/BW (mg/g) 1.8260.11 2.5960.24a 2.3260.54s 2.2360.32ab 2.3760.25a
HR, heart rate; LV, left ventricle; LVIDd, LV internal diastolic diameter; LVIDs, LV internal systolic diameter; LVM, LV mass; LVVd, LV end-diastolic volume; LVVs, LV end-
systolic volume; IVRT, isovolumetric relaxation time; SV, stroke volume; EF, ejection fraction. All values are means 6S. E.M, n = 8 per group.
aP,0.05 or P,0.01 compared to control groups,
bP,0.05 or P,0.01 compared to diabetes group.
doi:10.1371/journal.pone.0068949.t002
HIF-1a Signaling in Antioxidants Cardioprotection
PLOS ONE | www.plosone.org 5 July 2013 | Volume 8 | Issue 7 | e68949
Figure 2. Hemodynamic changes measured at baseline (10 minutes before ischemia), at 15 minutes of ischemia, at 60 minutes of
reperfusion, and at 120 minutes of reperfusion in diabetic rats with or without antioxidant treatment. Heart rate (HR), mean arterial
pressure (MAP) and rate pressure product (RPP) were measured at baseline and during ischemia and their area under the curves (AUC) are shown. C
and D indicate control or diabetes, respectively. D+NA, D+ NA+ SnPP-IX, D+NA+2ME2 indicates diabetic rats, treated with NAC+ALP (NA) or NA+SnPP-
IX or NA +2ME2, respectively. All values are expressed as means 6 S.E.M. (n = 7). *P,0.05or P,0.01 vs. their corresponding baseline; #P,0.05 or
P,0.01 vs. their corresponding D groups; &P,0.05 or P,0.01 vs. their corresponding D+NA groups.
doi:10.1371/journal.pone.0068949.g002
HIF-1a Signaling in Antioxidants Cardioprotection
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Figure 3. Effects of NAC and ALP on myocardial cell apoptosis assessed by TUNEL staining (A), and on cardiac and plasma 15-F2t-
IsoP before and after myocardial ischemia/reperfusion (MI/R) (B–E). TUNEL positive cells were stained brown as indicated by arrow (A).
Plasma and cardiac levels of 15-F2t-IsoP were assessed either after the completion of four weeks of NAC and ALP treatment (B, C) or after 30 minutes
of ischemia and two hours of reperfusion in control and diabetic rats (D, E). Sham, C and D indicate sham operation, control or diabetes respectively.
D+NA, D+ NA+SnPP-IX, D+NA+2ME2 indicate diabetic rats treated with NAC+ALP (NA) or NA +SnPP-IX or NA +2ME2, respectively. Data are expressed
as means 6S.E.M. (n = 7). *P,0.05 or P,0.01 vs. C; #P,0.05 vs. D, &P,0.05 vs. D+NA.
doi:10.1371/journal.pone.0068949.g003
HIF-1a Signaling in Antioxidants Cardioprotection
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Figure 4. Effects of NAC and ALP on Cu/Zn superoxide dismutase (Cu/Zn SOD) (A and B), Mn SOD protein expression (D and E)
before and after ischemia and reperfusion. Cardiac GSH/GSSG level before and after cardiac ischemia reperfusion(C and F).Sham, C and D
HIF-1a Signaling in Antioxidants Cardioprotection
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Results
General Characteristics and Plasma Glucose before
Inducing MI/R
STZ-injected rats had significant diabetic symptoms of hyper-
glycemia, polydipsia, polyphagia and weight loss. The plasma
glucose level, water intake and food consumption of the diabetic
rats increased but their body weight decreased compared to age-
matched normal rats (all P,0.05 D vs. C). NAC and ALP
increased water intake and food consumption (all P,0.05 D+NA
vs. D). NAC and/or ALP treatment had no significant effect on
body weight in diabetic rats. But in combination they reduced the
heart/body ratio that was elevated in diabetic rats (P,0.05 D+NA
vs. D; P,0.05 D vs. C). Plasma glucose was elevated in the
diabetic group as compared to controls. NAC and ALP given
alone or in combination had no significant impact on plasma
glucose (table 1).
NAC and ALP Attenuated Myocardial Injury in Diabetes
after MI/R
As shown in Fig. 1C and D, the cardiac area at risk did not
differ among groups, while MI/R resulted in moderate increase in
myocardial IS in diabetic rats (P.0.05 D. vs. C). NAC and ALP
reduced IS individually, while their combination yielded a
synergistic effect and further decreased IS in diabetic rats. SnPP-
IX or 2ME2 abolished the effect of NAC and ALP in reducing IS.
Post-ischemic plasma CK-MB levels were significantly higher in
diabetic groups as compared to control (P,0.05) which corre-
sponded to a larger IS in diabetic rats relative to C (Fig. 1E). NAC
and ALP conferred a synergistic effect in attenuating post-ischemic
CK-MB release in diabetic rats. Pretreatment with either SnPP-IX
or 2ME2 abolished the effect of NAC and ALP in reducing plasma
CK-MB.
Effect of NAC and ALP on Myocardial Injury and Function
before and after MI/R
Apoptotic myocardial cell death was significantly increased in
diabetic rats as evidenced by a larger number of TUNEL-staining
positive cells (73.3613.8% in group D vs. 5.661.2% in C,
P,0.01). Four weeks treatment with NAC or ALP given alone
significantly reduced the number of TUNEL-staining positive
cardiomyocytes while their combination did not further decrease
apoptotic myocardial cell death.
As shown in table 2, the echocardiography showed that the left
ventricular (LVM/BM) was significantly elevated in the diabetic
group compared to controls (P,0.01 vs. C), which was signifi-
cantly attenuated by treatment with NAC and ALP. The heart
rate in the diabetic rats as measured by echocardiography was
lower than that in the control rats, and neither NAC nor ALP or
their combination had significant impact on this parameter. The
LV dimensions of the diabetic hearts were decreased manifested as
reductions in LVIDd and LVVd (P,0.01 vs. C). These
parameters were not significantly affected by NAC and/or ALP.
The values of LVIDs and LVVs in diabetic rats did not
significantly differ from that in controls. However, NAC and
ALP significantly reduced LVVs (P,0.05, D+NA vs. D), resulting
in significantly enhanced LVEF (P,0.05, D+NA vs. D). The SV in
diabetic rats was significantly lower than that in the control group
(P,0.05) and ALP but not NAC significantly enhanced SV to a
level comparable to that in the control.
During MI/R, heart rate did not significantly differ among
groups over time (Fig. 2. A& B). Values for mean arterial blood
pressure (MAP, a major hemodynamic parameter) and the
product of heart rate and MAP (RPP) were relatively lower in
diabetic rats compared to control rats at baseline (i.e., before
inducing ischemia), but these difference did not reach statistical
significance (Fig. 2 C & E). However, during ischemia-reperfusion,
MAP and RPP were significantly lower in the diabetic group
compared to control, and NAC and ALP normalized MAP and
RPP (P.0.05 D+NA vs. C, P,0.05 D+NA vs. D). SnPP-IX and
especially 2ME2 abrogated the effects of NAC and ALP in
restoring normal values for MAP and RPP.
Oxidative Stress and Antioxidant Status before and after
Inducing MI/R
At baseline (i.e., before inducing ischemia) the plasma 15-F2t-
IsoP concentration was significantly higher in diabetic rats than in
controls, NAC and/or ALP normalized plasma 15-F2t-IsoP level
in the diabetic animals (Fig. 3B). Similarly, cardiac tissue 15-F2t-
IsoP was significantly increased in diabetic rats compared to
controls and NAC and/or ALP significantly reduced cardiac 15-
F2t-IsoP to a level comparable to that in the control group
(Fig. 3C).
After two hours of post-ischemic reperfusion, plasma and
cardiac 15-F2t-IsoP levels were significantly higher in diabetic
than in control rats (Fig. 3D and E). The NAC and ALP
combination treatment significantly reduced the plasma and
cardiac 15-F2t-IsoP level to a level comparable to that in the
control, while given alone the compounds did not significantly
attenuate the increase of plasma 15-F2t-IsoP during reperfusion
(Fig. 3D). HO-1 and HIF-1a inhibitors not only completely
cancelled the effect of NAC and ALP in reducing the 15-F2t-IsoP
level but further exacerbated post-ischemic oxidative stress as
evidenced by the further elevated 15-F2t-IsoP content compared
to the diabetic untreated group (All P,0.05, Fig. 3D and E).
At five weeks of diabetes, myocardial Cu/Zn SOD protein
expression was significantly increased (P,0.05 vs. C) (P,0.01 vs.
C, Fig. 4A). NAC or ALP partially, and their combination
significantly attenuated this compensatory increase in Cu/Zn
SOD protein expression. By contrast, myocardial Mn SOD
protein did not significantly change in diabetic rats five weeks after
STZ-injection and NAC and/or ALP treatment had no significant
effect on this protein (Fig. 4B). However, Cu/Zn SOD expression
significantly increased (P,0.05 vs. C Fig. 4D) while Mn SOD
expression moderately increased (P.0.05 vs. C. Fig. 4E) in the
diabetic group after MI/R. Both Cu/Zn SOD and Mn SOD
expressions were significantly decreased after MI/R in rats treated
with NAC and ALP (All P,0.05). The HIF-1a inhibitor 2ME2
but not the HO-1 inhibitor SnPP-IX prevented the significant
decreases in myocardial Cu/Zn SOD and Mn SOD protein after
MI/R following NAC and ALP treatment (Fig. 4D and E).
The cardiac GSH/GSSG ratio was significantly decreased in
five-weeks diabetic rats compared to the control group (P,0.05 vs.
C, Fig. 4C). NAC, but not ALP, restored the GSH/GSSG ratio.
The combinational use of NAC and ALP not only restored GSH/
GSSG ratio but further increased this ratio to a level higher than
that in the control group (P,0.05 D+NA vs. C). MI/R resulted in
dramatic reduction of GSH/GSSG ratio in the heart of diabetic
indicate sham operation, control or diabetes respectively. D+NA, D+ NA +SnPP-IX, D+NA+2ME2 indicate diabetic rats treated with NAC+ALP (NA) or
NA +SnPP-IX or NA +2ME2, respectively. Data are expressed as means 6 S.E.M. (n = 7) *P,0.05 vs. C; # P,0.05 vs. D.
doi:10.1371/journal.pone.0068949.g004
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rats as compared to control rats and NAC and ALP restored the
GSH/GSSG ratio back to the control level (Fig. 4F). However,
neither SnPP-IX nor 2ME2 were sufficient to abolish the
synergistic effect of NAC and ALP in restoring GSH/GSSG.
Effects of NAC and ALP on Myocardial HIF-1a/HO-1
Signaling in Diabetic Rats before and after MI/R
At five weeks of diabetes, myocardial HO-1 protein expression
was augmented in diabetic rats relative to controls (Fig. 5A). NAC
and the NAC/ALP combination but not ALP alone significantly
further increased the myocardial HO-1 protein level compared to
the untreated diabetic group (P,0.05, D+N or D+NA vs. D).
Consistent with these changes in HO-1 protein, myocardial HO-1
activity was increased in diabetic rats (P,0.05 D vs. C, Fig. 5C)
and NAC as well as the NAC plus ALP combination restored
myocardial HO-1 activity (P,0.05 D+N or D+NA vs. D;
P.0.05 D+N or D+NA vs. C, Fig. 5C).
After MI/R, myocardial HO-1 protein expression was dramat-
ically reduced in diabetic rats compared to non-diabetic control
(P,0.05, D vs. C; Fig. 5D). The NAC/ALP combination but not
NAC or ALP alone increased post-ischemic myocardial HO-1
protein expression in diabetic rats to a level significantly higher
than that in the untreated diabetic heart (P,0.05 D +NA vs. D),
while SnPP-IX and 2ME2 abolished the effects of NAC/ALP on
post-ischemic myocardial HO-1 protein (Fig. 5D).
Similar to the changes of myocardial HO-1 protein expression,
myocardial HIF-1a protein expression was significantly increased
in five-week diabetic rats (P,0.05 D vs. C, Fig. 5B). NAC/ALP
significantly enhanced cardiac HIF-1a protein expression
(P,0.05 D+NA vs. D; P.0.05 D+NA vs. C, Fig. 5B). After
MI/R, myocardial HIF-1a protein was significantly lower in
diabetic rats compared to control (Fig. 5E) and NAC/ALP
combination but not NAC or ALP alone restored post-ischemic
HIF-1a protein expression (P,0.05 D +NA vs. D; P.0.05 D
+NA vs. C, Fig. 5E). 2ME2 not only completely cancelled the
effects of NAC/ALP in restoring post-ischemic HIF-1a protein
expression, but further reduced HIF-1a protein to a level lower
than that in the diabetic untreated group (P,0.05 D+NA+2ME2
vs. D or D+NA, Fig. 5E). By contrast, SnPP-IX had no significant
effect on HIF-1a expression compared with the diabetic untreated
group.
Changes of HIF-1a/HO-1 Signaling and Antioxidant
Status in Cardiomyocytes Exposed to Hyperglycemia and
H/R
Following 45 minutes of hypoxia and 120 minutes of re-
oxygenation, HO-1 protein expression was significantly lower in
cardiomyocytes exposed to high than in those exposed to normal
glucose (P,0.05, Fig. 6A) while HIF-1a expression did not
significantly changed when cardiomyocytes were exposed to high
glucose and H/R (P.0.05, H-G+H/R vs. H/R, Fig. 6B). Cell
viability was significantly reduced (Fig. 7A) and cellular LDH
activity increased (Fig. 7B) in cardiomyocytes exposed to high
glucose. NAC and ALP normalized HO-1 protein expression in
high-glucose treated cardiomyocytes and prevented H/R induced
reduction of cell viability and increase in cellular LDH activity.
However, NAC and ALP increased cardiomyocyte HIF-1a
protein more than two fold (P,0.01 H-G+H/R+NA vs. H-
G+H/R, Fig. 6B), and this effect of the agents was inhibited by
2ME2. SnPP-IX or 2ME2 also abolished the effects of NAC and
ALP on post-hypoxic cardiomyocyte viability (Fig. 7A). SnPP-IX
not only reversed the effect of NAC and ALP in reducing
cardiomyocyte LDH release following H/R, but increased post-
H/R LDH release to a level higher than that observed in the high
glucose-untreated group (P,0.05 H-G+H/R+ NA+ SnPP-IX vs.
H-G+H/R, Fig. 7B).
HIF-1a and HO-1 were knocked down prior to inducing H/R
in H9C2 cell line. Transfection of H9C2 cells with HO-1 siRNA
or HIF-1a siRNA decreased the corresponding protein expression
by more than 90% (Fig. 6E). In line with the primary
cardiomyocyte experiments, the HO-1 (Fig. 6C) and HIF-1a
(Fig. 6D) protein expressions were decreased and LDH release was
increased in H9C2 cells after exposure to high glucose and H/R as
compared to the control group (Fig. 7F). NAC and ALP
normalized the HIF-1a and HO-1 protein expression and LDH
activity. The HIF-1a and HO-1 protein expressions were
decreased after transfection with their respective siRNA. HIF-1a
or HO-1 signaling knockdown significantly decreased HIF-1a and
HO-1 protein expression and resulted in increased post-H/R
LDH activity (P,0.05 H-G+H/R+NA+HIF-1a siRNA or H-
G+H/R+NA+HO-1 siRNA vs. H-G+H/R or H-G+H/R +NA,
Fig. 6 C, D and Fig. 7F).
Cardiomyocyte Mitochondrial Membrane Potential
(MMP) and Cell Injury
After H/R, the MMP loss in normal glucose treated cardio-
myocytes was about 22%, while in cardiomyocytes exposed to
high glucose, the percentage of loss was increased significantly
(P,0.05, H-G-H/R vs. H/R. Fig. 7G). This was accompanied by
significantly increases in cytosolic cytochrome c release (Fig. 7C)
and caspase3 activation (Fig. 7E) but by a significant reduction in
Mn SOD (Fig. 7D) as compared to normal glucose control (all
P,0.05). NAC and ALP treatment prevented high-glucose and
H/R mediated exacerbation of MMP loss increases in caspase3
activation and cytosolic cytochrome c release and as well as it
restored Mn SOD protein expression. These beneficial effects of
joint antioxidant NAC/ALP treatment were abolished by either
SnPP-IX or 2ME2.
Similarly, in cultured H9C2 cells, either HIF-1a or HO-1 gene
knockdown abrogated the effects of NAC/ALP in attenuating high
glucose and H/R induced increases in MMP (Fig. 7H) and cellular
LDH release (Fig. 7F).
Discussion
The present study shows that cardiac HIF-1a and HO-1 protein
expressions are reduced in diabetic hearts in vivo and in cultured
cardiomyocytes exposed in vitro to high glucose. These changes are
concomitant with increased oxidative stress and exacerbated
cardiomyocyte cellular injury after ischemic/hypoxic stimulation.
NAC and ALP synergistically attenuate post-ischemic injury and
cardiac dysfunction in type 1 diabetic rats and in isolated cultured
adult rat cardiomyocytes exposed to high glucose and H/R, an
effect associated with enhancement of cardiac HIF-1a/HO-1
signaling in response to MI/R. The subsequent attenuation of
Figure 5. HIF-1a/HO-1 level changes before and after 30 minutes of ischemia followed by two hours of reperfusion after four weeks
of NAC and ALP treatment. Myocardial HO-1 protein expression before (A) and after(C) MI/R. Myocardial HO-1 activity before(B) MI/R. HO-1activity
was determined by measuring bilirubin formation, and calculated as percentage with respect to control. Myocardial HIF-1a protein expression before
(D) and after (E) MI/R. Data are expressed as means6 S.E.M. (n = 8). *P,0.05 vs. C; #P,0.05 or p,0.01 vs. D, &P,0.01 vs. D+NA.
doi:10.1371/journal.pone.0068949.g005
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post-ischemic oxidative injury and the protective effects of NAC
and ALP were cancelled by inhibition of either HIF-1a or HO-1.
Similarly, in cultured adult rat cardiomyocytes exposed to high
glucose, the NAC and ALP exerted post-hypoxic cellular
protection was associated with enhancement of HIF-1a and
HO-1 protein expression. Indeed, inhibition of HIF-1a or HO-1
Figure 6. HO-1(A), HIF-1a (B) protein expression after 45 minutes of hypoxia followed by two hours of re-oxygenation in isolated
rat cardiomyocytes under high glucose stimulation in the absence or presence of selective inhibitors. HO-1 siRNA and HIF-1a siRNA
were applied, respectively, to knock down HO-1 and HIF-1a genes in H9c2 cell line and the effects were confirmed by assessing HO-1(C), HIF-1a (D)
protein expression. Representative Western blots of HO-1 and HIF-1a gene knock down in H9C2 cells exposed to high glucose (E). Data are expressed
as means6 S.E.M. of two independent experiments each performed in triplicate. *P,0.05 or P,0.01 vs. C; #P,0.05 or P,0.01 vs. H-G, &P,0.05, or
P,0.01 vs. H-G+NA.
doi:10.1371/journal.pone.0068949.g006
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Figure 7. Cardiomyocyte injury after 45 minutes of hypoxia followed by two hours of re-oxygenation under high glucose
stimulation. Effects of NAC/ALP on cell viability assessed by MTT assay (A), lactate dehydrogenase (LDH) release (B), Cytochrome c (C), Mn SOD (D)
expression and the ratio of activated caspase3/total caspase3 (E) and mitochondrial membrane potential(MMP) loss (G) in presence or absence of HIF-
1a/HO-1 signaling blockage in primary cultured cardiomyocytes. Effects of NAC/ALP on LDH release (F) and MMP loss in the presence or absence of
HIF-1 a/HO-1 gene silencing in H9C2 cell line (H). MMP loss is expressed as percentage of cells positive for green fluorescence as quantified from
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or their gene knockdown abrogated the protective effects of the
antioxidants. Thus, the present findings indicate that the
cardioprotective effects in diabetes resulting from the combination
of NAC plus ALP were achieved primarily through the restoration
of HIF-1a/HO-1 signaling in response to MI/R.
CK-MB, the sensitive cardiac injury marker, was significantly
higher in diabetic heart than that in the control rat after 30
minutes of ischemia and two hours of reperfusion, which indicated
that post-ischemic myocardial cellular injury is more severe in
diabetic than that in the control rats. Infarct size is viewed as the
gold standard in assessing the severity of post-ischemic myocardial
injury, while CK-MB is a reliable predictor of post-ischemic
myocardial infarction in patients after acute myocardial ischemia
[45,46]. In patients with acute myocardial ischemia, the plasma
CK-MB level peaks about ten hours after ischemia and predicts
well myocardial infract size (IS) five to seven days after reperfusion
with thrombolytic therapy [46]. Plasma CK-MB levels correlate
inversely with post-ischemic left ventricular function and myocar-
dial infarction five to ten days after an ischemic episode [31].
Similarly, previous findings in isolated ischemic reperfused rat
hearts showed that the increase in post-ischemic CK-MB peaked
minutes after reperfusion while significant myocardial IS did not
become apparent until after one hour of reperfusion [47]. In the
present study, significantly higher post-ischemic CK-MB levels in
diabetic rats at reperfusion correlated with more severely impaired
post-ischemic left ventricular function as compared to controls.
The increase (compared with controls) in post-ischemic IS in the
diabetic rats in the present study did not reach statistical
significance despite the significant increase in CK-MB level. A
possible reason may be that the reperfusion time of 120 minutes
was not long enough to catch significant increase in IS in the
diabetic group when using 30 minutes of coronary ligation model,
given that an in vivo study in mice shows that post-ischemic
myocardial IS progressively increases when reperfusion time varies
from 120 minutes to 240 minutes after 30 to 40 minutes of
coronary artery occlusion [48]. Significantly higher levels of CK-
MB and more severe impairment in post-ischemic left ventricular
function in the diabetic rats as shown in the present study indicate
that myocardial injury is more severe in diabetic than in control
rats. The antioxidants NAC and ALP achieve synergy in
enhancing endogenous antioxidant capacity and most profoundly
attenuate post-ischemic MI/R injury in diabetes.
Earlier observation [49] demonstrated that NAC treatment
alone attenuated but did not prevent myocardial dysfunction in
diabetic rats. Similarly, experimental antioxidant treatment with
single agents has been shown to attenuate but not to prevent
myocardial ischemia-reperfusion injury [50,51] and cardiac
dysfunction both in normal and in diabetic subjects [52,53]. In
the present study, NAC and ALP in combination, but neither one
of them alone as shown in a previous study [22] normalized post-
ischemic mean arterial blood pressure in diabetic rats and
significantly reduced post-ischemic myocardial infarction, which
may be explained in part through additional effects resulting from
the different antioxidant properties of the two agents.
ALP, a xanthine oxidase inhibitor, attenuates diabetes-induced
ROS production, and unlike NAC it also improves diabetes-
induced cardiac dysfunction [54]. Xanthine oxidase, a source of
ROS, is increased in the ischemic tissue as a result of enhanced
conversion of xanthine dehydrogenase to xanthine oxidase [55],
which increases oxidative stress and exacerbates tissue ischemic
injury [36]. Increased xanthine oxidase/hypoxanthine activity
prompts opening of cardiac mitochondrial permeability transition
pore (MPTP) and exacerbates cardiomyocyte injury [56]. There-
fore, combating ROS-induced cellular damage and preventing
MPTP opening by enhancing GSH/GSSG (the largest capacity
thiol buffer in the cell, the reduction of which is one of the major
mechanisms that prompt the opening of MPTP in diabetes [57])
and inhibiting xanthine oxidase could be the fundamental
mechanism explaining why NAC and ALP attenuate the
augmented myocardial post-ischemic injury in diabetic rats and
ameliorate post-hypoxic cardiomyocyte injury under high glucose
stimulation. Oxidative stress was increased under diabetic
conditions and accompanied by the development of diabetic
cardiomyopathy, with apoptosis and fibrosis as early features of
heart failure. ALP, as shown in a previous study [30] and the study
of Rajesh and colleagues [58] significantly attenuated the
development of cardiac fibrosis and dysfunction in diabetic
rodents. Further, the finding of the present study that ALP
significantly reduced myocardial apoptosis and caspase3 activation
in diabetic rats is in keeping with the findings of Rajesh and
colleagues [58] who showed that ALP treatment, in addition to
reducing oxidative and nitrative stress, reduced myocardial
apoptotic cell death in a mouse model of STZ-induced type 1
diabetes. These properties of ALP can be attributed to the NAC/
ALP synergistic myocardial protection demonstrated in the
current study. During the combined NAC and ALP treatment,
the improvement of left ventricular function prior to inducing
myocardial ischemia as shown by echocardiograph study should
also have contributed in part to the attenuation of post-ischemic
myocardial injury in the diabetic animals.
NAC, a precursor of GSH, conferred its antioxidant effect in the
diabetic myocardium primarily via enhancing endogenous GSH/
GSSG but not via myocardial SOD. That NAC/ALP treatment
can enhance endogenous GSH/GSSG to a level higher than
observed in control rats at basal may explain why chronic NAC/
ALP treatment prevented the compensatory increase in myocar-
dial Cu/Zn SOD in diabetes or even reduced cardiac Cu/Zn
SOD and Mn SOD after ischemia, but still decreased cardiac and
plasma 15-F2t-Isop to levels comparable to those in the control
group and also reduced post-ischemic myocardial infarction in the
diabetic rats.
In addition, the cardioprotective effects of the NAC and ALP
combination are associated with attenuation of the loss of
cardiomyocyte MMP after exposure to high glucose and
hypoxia/re-oxygenation. Mitochondria are both a major source
of ROS and also a critical target during oxidative damage.
Therefore, mitochondrial oxidative stress-induced dysfunction has
been implicated in the pathogenesis of many diseases such as
diabetes and ischemia/reperfusion injury. Cytochrome c release
from mitochondria and MMP loss (which leads to the increase in
MPTP opening) are critical events resulting in cell apoptosis [59].
Reduction in Mn SOD and the subsequent increase in mitochon-
microscopy images. Representative images of mitochondrial membrane potential loss in primarily cultured cardiomyocytes (I, upper lane) and H9C2
cell lines (I, lower lane). Isolated adult primary cardiomyocytes or H9C2 cell lines were plated at a density of 56104 cells/well with 48 h high glucose
treatment. All cells were subjected to 45 minutes hypoxia and two hours of re-oxygenation with or without antioxidant treatment or with HIF-1a or
HO-1 gene knockdown. Cells had strongest J-aggregation (red, 560/595 nm) due to high MMP and cells stained green (485/535 nm) had low MMP.
Data are expressed as means6 S.E.M. of two independent experiments each performed in triplicate (n = 6 per group). *P,0.05 or P,0.01 vs. H/R;
#P,0.05 or P,0.01 vs. H-G+H/R, &P,0.05, or P,0.01 vs. H-G+H/R+NA.
doi:10.1371/journal.pone.0068949.g007
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drial oxidative stress play important roles in this pathology. The
present study shows that NAC/ALP attenuated the increased
release of cytosolic cytochrome c and the decrease of Mn SOD
and MMP through mechanisms that involve HIF-1a/HO-1
signaling. The novel finding that NAC and ALP attenuate high
glucose-induced MPTP opening in cardiomyocytes during hyp-
oxia/re-oxygenation via HIF-1a/HO-1 signaling may have
potential clinical importance in guiding the development of
effective therapies to combat myocardial ischemia in diabetes.
Indeed, mitochondria from diabetic hearts are more sensitized to
MPTP opening than those from non-diabetic hearts as a result of
redox-dependent shifts in MPTP opening [57]. The latter could be
the major reason why diabetic hearts are more vulnerable to
ischemic insult.
The antioxidants NAC and ALP, at doses that can normalize
the levels of the specific oxidative stress index 15-F2t-IsoP,
stabilized cardiac HIF-1a, moderately enhanced HIF-1a protein
expression in the diabetic myocardium, and subsequently atten-
uated post-ischemic myocardial injury. Of particular interest,
NAC and ALP acted synergistically to enhance myocardial HIF-
1a protein expression and most prominently reduced post-
ischemic myocardial injury. This synergistic cardioprotection
exerted by NAC and ALP in a model of myocardial ischemia-
reperfusion injury in diabetic animals was prevented by in vivo
administration of either HO-1 or HIF-1a inhibitors. Likewise,
in vitro knockdown of HO-1 or HIF-1a to prevent NAC/ALP
mediated enhancement of HO-1 or HIF-1a, suppressed the
protection exerted by the antioxidants against cardiomyocyte post-
hypoxic cellular injury and was accompanied by a loss of cell
MMP. Thus, the results from the present study indicate that
activation of cardiac HIF-1a and its downstream molecular target
HO-1 play a key role in antioxidant cardioprotection in the
diabetic heart.
The cardiac HIF-1 a/HO-1 levels were increased in response to
I/R or H/R stimulation compared to control while the post-
ischemic cardiac HIF-1 a/HO-1 levels were decreased both in
diabetic rats and in isolated cardiomyocytes under high glucose
conditions. This is consistent with and extends the finding of
Marfella and colleagues who showed that HIF-1 a activation
played a critical in maintaining myocardial viability in diabetic
mice [8]. Indeed, HIF-1 a/HO-1 signaling plays an important role
in the cardiovascular system [60]. Taken in conjunction, the
findings by others and the present results suggest that the HIF-1 a/
HO-1 pathway plays an essential role in cardioprotection against
MI/R injury in diabetes, although the detailed regulation of the
involvement of HIF-1a/HO-1 signaling warrants further investi-
gation.
In summary, the present study demonstrates that NAC and
ALP act synergistically in reducing MI/R injury in diabetes
primarily by restoration of the HIF-1 a/HO-1 signaling. These
results provide insight into the effects and mechanisms of action of
antioxidants therapy that may lead to the development of effective
therapeutic regimens to combat the myocardial complications of
diabetes.
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